Indrayani Biotech Ltd
BSE:526445
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (12.6), the stock would be worth ₹0.82 (93% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 185.2 | ₹12.08 |
0%
|
| 3-Year Average | 12.6 | ₹0.82 |
-93%
|
| 5-Year Average | 7.7 | ₹0.51 |
-96%
|
| Industry Average | 18.9 | ₹1.23 |
-90%
|
| Country Average | 17.7 | ₹1.15 |
-90%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
|
Indrayani Biotech Ltd
BSE:526445
|
550.1m INR | 185.2 | -7.5 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
267.2B USD | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 3 417.4 | 4 020.7 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
102.7B ZAR | 14.4 | 10.6 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
68.1B USD | -18 026.5 | 38 496.8 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
57.8B USD | 0 | 0 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
35.8B CHF | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
33.1B EUR | 32.1 | 175.5 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
37.9B USD | -4 589.3 | -3 457.3 | |
| ZA |
V
|
Vukile Property Fund Ltd
JSE:VKE
|
30.2B ZAR | 17.7 | 7 |
Market Distribution
| Min | 0.4 |
| 30th Percentile | 11.9 |
| Median | 17.7 |
| 70th Percentile | 27.8 |
| Max | 47 834.4 |
Other Multiples
Indrayani Biotech Ltd
Glance View
Indrayani Biotech Ltd. provides health care services. The company is headquartered in Pune, Maharashtra. The firm is primarily operating in three divisions, which include Foods & Hospitality, Engineering and Healthcare divisions. Its Foods & Hospitality division is engaged in full range of food supply services on a contract basis to colleges and universities, hospitals and healthcare institutions, corporate office, industries and information technology (IT). Its Engineering division products range include battery charger, modular, industrial and commercial on-line ups system, industrial inverters, alternating current (AC)/ direct current (DC) power supplies, servo-controlled voltage stabilizer, and special purpose machines (SPM). In Healthcare divisions the Company operates eye care hospitals.
